EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Electronic Glycemic Management System Improved Glycemic Control and Reduced Complications in Patients With Diabetes Undergoing Coronary Artery Bypass Surgery: A Randomized Controlled Trial

Alexandre Barbosa Câmara de Souza iD, Marcos Tadashi Kakitani Toyoshima iD, Priscilla Cukier, Simão Augusto Lottenberg, Paula Mathias Paulino Bolta, Eduardo Gomes Lima, Carlos Vicente Serrano Júnior, Marcia Nery iD

Journal of Diabetes Science and Technology · 2026

DOI: 10.1177/19322968241268352 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Diabetes Science and Technology, 2026. Verfasst von Alexandre Barbosa Câmara de Souza und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Coronary Artery Bypass, Glycemic Control, Diabetes Mellitus, Type 2, Blood Glucose. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In-hospital hyperglycemia poses significant risks for patients with diabetes mellitus undergoing coronary artery bypass graft (CABG) surgery. Electronic glycemic management systems (eGMSs) like InsulinAPP offer promise in standardizing and improving glycemic control (GC) in these settings. This study evaluated the efficacy of the InsulinAPP protocol in optimizing GC and reducing adverse outcomes post-CABG.

Methods

This prospective, randomized, open-label study was conducted with 100 adult type 2 diabetes mellitus (T2DM) patients post-CABG surgery, who were randomized into two groups: conventional care (gCONV) and eGMS protocol (gAPP). The gAPP used InsulinAPP for insulin therapy management, whereas the gCONV received standard clinical care. The primary outcome was a composite of hospital-acquired infections, renal function deterioration, and symptomatic atrial arrhythmia. Secondary outcomes included GC, hypoglycemia incidence, hospital stay length, and costs.

Results

The gAPP achieved lower mean glucose levels (167.2 ± 42.5 mg/dL vs 188.7 ± 54.4 mg/dL; P = .040) and fewer patients-day with BG above 180 mg/dL (51.3% vs 74.8%, P = .011). The gAPP received an insulin regimen that included more prandial bolus and correction insulin (either bolus-correction or basal-bolus regimens) than the gCONV (90.3% vs 16.7%). The primary composite outcome occurred in 16% of gAPP patients compared with 58% in gCONV ( P < .010). Hypoglycemia incidence was lower in the gAPP (4% vs 16%, P = .046). The gAPP protocol also resulted in shorter hospital stays and reduced costs.

Conclusions

The InsulinAPP protocol effectively optimizes GC and reduces adverse outcomes in T2DM patients’ post-CABG surgery, offering a cost-effective solution for inpatient diabetes management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery BypassGlycemic ControlDiabetes Mellitus, Type 2Blood GlucosePostoperative ComplicationsHumansMaleFemaleMiddle AgedAgedInsulinProspective StudiesHypoglycemic AgentsTreatment OutcomeHypoglycemiaLength of Stay

Stichwörter der Autor:innen

digital health protocolin-hospital hyperglycemiainsulin therapymedical informatics applicationsnon-critically ill inpatientstype 2 diabetes mellitus

Substanzen

Blood GlucoseInsulinHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Oncoendocrinology Service, Instituto do Câncer do Estado de São Paulo Octávio Frias de Oliveira, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Instituto do Coração, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

ORCID-Profile: Alexandre Barbosa Câmara de Souza, Marcos Tadashi Kakitani Toyoshima, Marcia Nery

Zitieren

APA

Câmara de Souza, A. B., Toyoshima, M. T. K., Cukier, P., Lottenberg, S. A., Bolta, P. M. P., Lima, E. G., Serrano Júnior, C. V., & Nery, M. (2026). Electronic Glycemic Management System Improved Glycemic Control and Reduced Complications in Patients With Diabetes Undergoing Coronary Artery Bypass Surgery: A Randomized Controlled Trial. Journal of Diabetes Science and Technology. https://doi.org/10.1177/19322968241268352

Vancouver

Câmara de Souza AB, Toyoshima MTK, Cukier P, Lottenberg SA, Bolta PMP, Lima EG, et al. Electronic Glycemic Management System Improved Glycemic Control and Reduced Complications in Patients With Diabetes Undergoing Coronary Artery Bypass Surgery: A Randomized Controlled Trial. Journal of Diabetes Science and Technology. 2026. doi:10.1177/19322968241268352

BibTeX
@article{CmaradeSouza2026,
  author = {Câmara de Souza, Alexandre Barbosa and Toyoshima, Marcos Tadashi Kakitani and Cukier, Priscilla and Lottenberg, Simão Augusto and Bolta, Paula Mathias Paulino and Lima, Eduardo Gomes and Serrano Júnior, Carlos Vicente and Nery, Marcia},
  title = {Electronic Glycemic Management System Improved Glycemic Control and Reduced Complications in Patients With Diabetes Undergoing Coronary Artery Bypass Surgery: A Randomized Controlled Trial},
  journal = {Journal of Diabetes Science and Technology},
  year = {2026},
  doi = {10.1177/19322968241268352}
}
Kostenlos starten →